Durham pharma lands $2.5M from NIH to target Alzheimer's disease

A Durham pharmaceutical company has landed a $2.5 million award from the federal government to advance its treatment for Alzheimer's disease.

Source: bizjournals.com Health Care:Biotechnology headlines - October 5, 2022 Category: Biotechnology Authors: Zac Ezzone Source Type: news